Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2015-04-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis
NCT05190562
Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste
NCT02992314
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064
Clinical Study New Gel for Xerostomia
NCT04184908
Carnosine Supplementation on Quantity/Quality of Oral Salivae.
NCT04295525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It has been proposed that zinc deficiency is one of the causes for development of taste disorders. The aim of this study is to describe the presence of taste disorders in patients with cirrhosis and evaluate the effect of zinc supplementation in treatment of taste disorders, and in progression of chronic liver disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
100 mg placebo
100 mg Placebo plus nutritional education
Placebo
Nutritional education
100 mg zinc supplement
Nutritional education plus 100 mg of zinc gluconate
zinc gluconate
Zinc supplementation plus nutritional education
Nutritional education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
zinc gluconate
Zinc supplementation plus nutritional education
Placebo
Nutritional education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with any neurological disease
* Patients with respiratory diseases ath the time of dysgeusia evaluation
* Patients with active alcohol consumption
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Clínica Médica Sur
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Norberto Carlos Chavez Taia
Obesity and Digestive Diseases Unit Chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norberto C Chávez-Tapia, PhD
Role: PRINCIPAL_INVESTIGATOR
Medica Sur Clinic & Foundation
Eva Juárez-Hernández
Role: STUDY_DIRECTOR
Medica Sur Clinic & Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medica Sur Clinic & Foundation
Mexico City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cirrhosis01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.